HSP90AA1 and cancer: For this purpose, eleven HSP90 inhibitors were tested to inhibit cancer growth and MDR caused by P-gp, and 3 out of the 11 tested compounds succeeded in inhibiting P-gp overexpression and MDR together with HSP90 in CRC cells.